Search - tctmd.com

Displaying 841 - 860 of 2580

Sort: Relevancy | Date

Presentation TCT 2015

Other Important TAVR Studies 3: CHOICE Late Follow-up

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Mohamed Abdel-Wahab

October 11, 2015

Presentation TCT 2015

Other Important TAVR Studies 2: The NOTION All-Comer TAVR RCT

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Lars Sondergaard

October 11, 2015

Presentation TCT 2015

Other Important TAVR Studies 1: Updates From the TVT Registry

Presenter: Samir R. Kapadia, Jeffrey J. Popma, John D. Carroll

October 11, 2015

Presentation TCT 2015

Lessons From the EU TAVR Registries 4: GARY (Surgery and TAVR)

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Thomas Walther

October 11, 2015

Presentation TCT 2015

Lessons From the EU TAVR Registries 3: FRANCE 2 (and More)

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Martin B. Leon

October 11, 2015

Presentation TCT 2015

Lessons From the EU TAVR Registries 2: The UK Registry

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Neil E. Moat

October 11, 2015

Presentation TCT 2015

Lessons From the EU TAVR Registries 1: ADVANCE

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Axel Linke

October 11, 2015

Presentation TCT 2015

Updates From the PARTNER Trials 2: Reports From Selected Substudies

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Darshan Doshi

October 11, 2015

Presentation TCT 2015

Updates From the PARTNER Trials 1: Follow-up From the Inoperable and High-Risk Subgroups

Presenter: Samir R. Kapadia, Jeffrey J. Popma

October 11, 2015

Presentation TCT 2015

Updates From the US CoreValve Studies 2: Reports From Selected Substudies

Presenter: Samir R. Kapadia, Jeffrey J. Popma

October 11, 2015

Presentation TCT 2015

Updates From the US CoreValve Studies 1: Follow-up From the Extreme and High-Risk Subgroups

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Michael J. Reardon

October 11, 2015

Presentation TCT 2015

Status Updates on New TAVR Indications 5: Predominant Aortic Regurgitation

Presenter: Martin B. Leon, Neil E. Moat, Hendrik Treede

October 11, 2015

Presentation TCT 2015

Status Updates on New TAVR Indications 4: Aortic Stenosis + Mitral Regurgitation

Presenter: Martin B. Leon, Neil E. Moat, Simon Redwood

October 11, 2015

Presentation TCT 2015

Status Updates on New TAVR Indications 3: Aortic Stenosis + Coronary Artery

Presenter: Martin B. Leon, Neil E. Moat, David Hildick-Smith

October 11, 2015

Presentation TCT 2015

Status Updates on New TAVR Indications 2: Low-Flow (Low-Gradient) AS

Presenter: Martin B. Leon, Neil E. Moat, Howard C. Herrmann

October 11, 2015

Presentation TCT 2015

Status Updates on New TAVR Indications 1: Bicuspid Aortic Valve Disease

Presenter: Martin B. Leon, Neil E. Moat, John G. Webb

October 11, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Transcatheter Valve Replacement for Bioprosthetic Valve Failure Gold Standard vs Selective Application (The VIVID Registry)

Presenter: Martin B. Leon, Neil E. Moat, Danny Dvir

October 11, 2015

Presentation TCT 2015

Predicting the Future of Open Surgery for Aortic Stenosis: The TAVR Effect

Presenter: Martin B. Leon, Neil E. Moat

October 11, 2015

Presentation TCT 2015

Status Update on Moderate-Risk TAVR RCTs 2: SURTAVI

Presenter: Martin B. Leon, Neil E. Moat, Patrick W. Serruys

October 11, 2015

Presentation TCT 2015

Status Update on Moderate-Risk TAVR RCTs 1: PARTNER IIA

Presenter: Martin B. Leon, Neil E. Moat

October 11, 2015

Advertisement

Other Important TAVR Studies 3: CHOICE Late Follow-up

Other Important TAVR Studies 2: The NOTION All-Comer TAVR RCT

Other Important TAVR Studies 1: Updates From the TVT Registry

Lessons From the EU TAVR Registries 4: GARY (Surgery and TAVR)

Lessons From the EU TAVR Registries 3: FRANCE 2 (and More)

Lessons From the EU TAVR Registries 2: The UK Registry

Lessons From the EU TAVR Registries 1: ADVANCE

Updates From the PARTNER Trials 2: Reports From Selected Substudies

Updates From the PARTNER Trials 1: Follow-up From the Inoperable and High-Risk Subgroups

Updates From the US CoreValve Studies 2: Reports From Selected Substudies

Updates From the US CoreValve Studies 1: Follow-up From the Extreme and High-Risk Subgroups

Status Updates on New TAVR Indications 5: Predominant Aortic Regurgitation

Status Updates on New TAVR Indications 4: Aortic Stenosis + Mitral Regurgitation

Status Updates on New TAVR Indications 3: Aortic Stenosis + Coronary Artery

Status Updates on New TAVR Indications 2: Low-Flow (Low-Gradient) AS

Status Updates on New TAVR Indications 1: Bicuspid Aortic Valve Disease

KEYNOTE LECTURE: Transcatheter Valve Replacement for Bioprosthetic Valve Failure Gold Standard vs Selective Application (The VIVID Registry)

Predicting the Future of Open Surgery for Aortic Stenosis: The TAVR Effect

Status Update on Moderate-Risk TAVR RCTs 2: SURTAVI

Status Update on Moderate-Risk TAVR RCTs 1: PARTNER IIA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content